Patricia Piedra

Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin

M. S. Ramakrishnan, T. Crombet, H. Iyer, 2009, mAbs.

Efficacy and Safety of ior® EPOCIM for Chemotherapy- or Radiotherapy-Induced Anemia in Pediatric Cancer Patients

I. Caballero, Patricia Piedra, G. Saurez, 2010 .

Clinical experience with nimotuzumab in cuban pediatric patients with brain tumors, 2005 to 2007.

A. Lage, M. Longchong, Patricia Piedra, 2009, MEDICC review.

Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trial

M. Deng, Xiao-jing Du, Shao-xiong Wu, 2019, Journal of Cancer.

Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.

Glay Chinea, Osmany Guirola, Vivian Huerta, 2008, Hybridoma.